ClinicaliQ Trial Snapshot
- A Phase 2 Trial to Investigate Efficacy and Safety of Vipoglanstat in Women With Endometriosis — Recruiting • Phase II • Women's Health • NCT07260669.
- A study testing whether vipoglanstat reduces pelvic pain in women with endometriosis, beyond pain linked to periods.
Verify eligibility, endpoints and current status on the original ClinicalTrials.gov registry before acting on this summary.
Use This Page For
- Quick orientation before opening the registry record.
- Checking recruitment status, phase and sponsor at a glance.
- Connecting this trial to nearby guidelines, Drug Science and education.
What This Trial Is Studying
The main objective of the trial is to evaluate the efficacy of vipoglanstat on endometriosis-related non-menstrual pelvic pain (NMPP). Conditions: Endometriosis Interventions: Vipoglanstat, Placebo Lead Sponsor: Gesynta Pharma AB Planned Enrollment: 190 participants